Alex Straumann Selected Research

Alex Straumann Research Topics

Disease

40	Eosinophilic Esophagitis 04/2024 - 07/2002
10	Crohn Disease (Crohn's Disease) 12/2020 - 06/2005
9	Inflammation (Inflammations) 01/2020 - 11/2010
7	Pathologic Constriction (Stenosis) 10/2022 - 01/2012
5	Ulcerative Colitis 12/2020 - 06/2005
5	Eosinophilia 03/2018 - 04/2003
3	Esophageal Diseases 01/2018 - 01/2016
2	Infections 01/2021 - 04/2016
2	Hypersensitivity (Allergy) 12/2020 - 07/2011
2	Asthma (Bronchial Asthma) 01/2020 - 07/2002
2	Eosinophilic enteropathy 01/2019 - 10/2007
2	Deglutition Disorders (Dysphagia) 01/2019 - 11/2010
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 05/2012
2	Leukocytosis (Pleocytosis) 01/2010 - 12/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 12/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Neoplasms (Cancer) 01/2019
1	Celiac Disease (Celiac Sprue) 08/2017
1	Cholangiocarcinoma 01/2017
1	Mycoses (Diseases, Fungus) 03/2016
1	Colitis 06/2015
1	Necrosis 11/2013
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2013
1	Egg Hypersensitivity (Egg Allergy) 10/2012
1	Atrophy 05/2011
1	Disease Susceptibility (Diathesis) 07/2009
1	Gastroesophageal Reflux (GERD) 07/2009
1	Sepsis (Septicemia) 09/2008
1	Wells syndrome 04/2003
1	Atopic Dermatitis (Atopic Eczema) 07/2002
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 07/2002
1	Nasal Polyps (Nasal Polyp) 07/2002
1	Parasitic Diseases (Parasitic Disease) 07/2002

Drug/Important Bio-Agent (IBA)

12	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 10/2007
9	Budesonide (Pulmicort)FDA LinkGeneric 12/2020 - 11/2010
6	SteroidsIBA 01/2022 - 03/2016
6	Proton Pump InhibitorsIBA 01/2020 - 02/2009
4	AllergensIBA 01/2021 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2010
4	TabletsIBA 12/2020 - 01/2019
4	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2020 - 12/2009
4	Certolizumab Pegol FDA Link 01/2017 - 06/2010
3	Interleukin-13IBA 01/2021 - 07/2002
3	AntigensIBA 01/2018 - 07/2011
3	C-Reactive ProteinIBA 02/2013 - 12/2009
2	Monoclonal AntibodiesIBA 01/2021 - 01/2019
2	cendakimabIBA 01/2021 - 01/2019
2	Fluticasone (Cutivate)FDA LinkGeneric 01/2020 - 12/2018
2	CytokinesIBA 01/2020 - 07/2002
2	Immunologic Factors (Immunomodulators)IBA 01/2019 - 11/2013
2	Immunoglobulin E (IgE)IBA 01/2013 - 05/2005
2	Adalimumab (Humira)FDA Link 08/2012 - 01/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 08/2008
2	Infliximab (Remicade)FDA Link 08/2012 - 08/2008
2	mepolizumabIBA 07/2010 - 01/2009
1	RNA (Ribonucleic Acid)IBA 04/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2020
1	vedolizumabIBA 01/2019
1	ZincIBA 01/2018
1	EpitopesIBA 08/2017
1	Interleukin-15 (Interleukin 15)IBA 08/2017
1	Tumor Necrosis Factor InhibitorsIBA 06/2015
1	Calcineurin InhibitorsIBA 06/2015
1	Hemoglobins (Hemoglobin)IBA 02/2013
1	EnzymesIBA 01/2013
1	GlucocorticoidsIBA 01/2013
1	Cytochrome P-450 CYP3AIBA 01/2013
1	Anti-Allergic Agents (Antiallergic Agents)IBA 12/2012
1	Chemokine CCL26IBA 07/2009
1	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 09/2008
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 10/2007
1	Azathioprine (Imuran)FDA LinkGeneric 10/2007
1	InterleukinsIBA 12/2003
1	Eosinophil Cationic ProteinIBA 04/2003
1	Interleukin-2 (IL2)IBA 04/2003
1	Platelet Activating FactorIBA 04/2003
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 04/2003

Therapy/Procedure

21	Therapeutics 10/2022 - 08/2008
2	Ambulatory Care (Outpatient Care) 01/2022 - 01/2022
2	Endoscopes 01/2016 - 12/2013
2	Immunotherapy 01/2013 - 10/2012
1	Duration of Therapy 01/2021
1	Withholding Treatment 01/2018
1	Liver Transplantation 01/2017
1	Surgical Instruments (Clip) 12/2016
1	Colectomy 06/2015
1	Punctures 09/2008
1	Ligation 09/2008
1	Complementary Therapies (Alternative Medicine) 06/2005